Literature DB >> 1452065

Epidermal growth factor in the oesophagus.

J Jankowski1, G Coghill, B Tregaskis, D Hopwood, K G Wormsley.   

Abstract

Epidermal growth factor (EGF) has been implicated in mitogenesis and oncogenesis in the gastrointestinal tract. To determine the role of EGF in oesophageal disease, its quantity and distribution in the oesophageal mucosa of control subjects and patients with oesophageal disease were studied. Oesophageal biopsy specimens, taken 20-40 cm from the incisors in 72 patients, were graded histologically and adjacent specimens were taken for immunohistochemical analysis of the distribution of EGF. In patients with Barrett's columnar lined oesophagus, specimens were also taken from the gastric cardia for comparison. Twenty two biopsy specimens showed oesophagitis, 20 Barrett's mucosa, and 30 were histologically normal. EGF was found in the capillary endothelium of the normal oesophageal papillae and basal mucosa. Significantly more EGF positive papillae were found in the normal mucosa (81%) than in the inflamed mucosa (42%) (p < 0.001). The 20 patients with Barrett's mucosa showed abnormal expression of EGF in 25% of the isthmus and superficial epithelial cells. This study has shown that EGF is found only in the endothelial cells of the capillaries of the normal oesophageal mucosa and that the peptide is detectable significantly less frequently than normal in the inflamed oesophageal mucosa. EGF is also abnormally present, in large quantities, in the cytoplasm of the epithelial cells of Barrett's mucosa compared with gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452065      PMCID: PMC1379525          DOI: 10.1136/gut.33.11.1448

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Morphologic demonstration of receptor-mediated endocytosis of epidermal growth factor by isolated bile duct epithelial cells.

Authors:  M Ishii; B Vroman; N F LaRusso
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

2.  The correlation of epidermal growth factor with invasion and metastasis in human gastric cancer.

Authors:  M Onda; A Tokunaga; K Nishi; T Yoshiyuki; Y Shimizu; T Kiyama; T Mizutani; N Matsukura; N Tanaka; K Yamashita
Journal:  Jpn J Surg       Date:  1990-05

3.  Identification and localization of epidermal growth factor and its receptor in the human glomerulus.

Authors:  K Yoshioka; T Takemura; K Murakami; N Akano; K Matsubara; N Aya; S Maki
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

4.  Radioimmunoassay of human epidermal growth factor (urogastrone).

Authors:  R H Starkey; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

5.  Epidermal growth factor stimulates synthesis and secretion of mucus glycoproteins in human gastric mucosa.

Authors:  S M Kelly; J O Hunter
Journal:  Clin Sci (Lond)       Date:  1990-11       Impact factor: 6.124

6.  Distribution and release of epidermal growth factor in man.

Authors:  J W Konturek; W Bielanski; S J Konturek; J Bogdal; J Oleksy
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

7.  Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy.

Authors:  K Shirasuna; Y Hayashido; M Sugiyama; H Yoshioka; T Matsuya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.

Authors:  S J Konturek; A Dembinski; Z Warzecha; W Bielanski; T Brzozowski; D Drozdowicz
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

9.  Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Authors:  Y Oka; D N Orth
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

10.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.

Authors:  B J Reid; R C Haggitt; C E Rubin; P S Rabinovitch
Journal:  Gastroenterology       Date:  1987-07       Impact factor: 22.682

View more
  15 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 3.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

4.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

Review 5.  Functional oesophageal epithelial defense against acid.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Kazunari Tominaga; Toshio Watanabe; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

6.  Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor.

Authors:  A I Lanas; J M Blas; J Ortego; J Soria; R Sáinz
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

7.  Gene expression in Barrett's mucosa: acute and chronic adaptive responses in the oesophagus.

Authors:  J Jankowski
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

8.  Role of salivary and seric epidermal growth factor in pathogenesis of reflux esophagitis in chronic alcoholics and nondrinkers.

Authors:  R Benamouzig; F Ferrière; C Guettier; J Amouroux; T Coste; J Rautureau
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

9.  Gastric acid normosecretion is not essential in the pathogenesis of mild erosive gastroesophageal reflux disease in relation to Helicobacter pylori status.

Authors:  Tomohiko Shimatani; Masaki Inoue; Nobue Harada; Yoko Horikawa; Masuo Nakamura; Susumu Tazuma
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

10.  Short segment Barrett's oesophagus: prevalence, diagnosis and associations.

Authors:  S Nandurkar; N J Talley; C J Martin; T H Ng; S Adams
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.